'Pharma Bro' Martin Shkreli Gets 7 Years In Prison For Securities Fraud

Justice came for Martin Shkreli.

The so-called “Pharma Bro” was sentenced Friday to 84 months in prison after having been convicted in August 2017 on two counts of securities fraud and one count of conspiracy to commit securities fraud. Prosecutors were looking for 15 years prison time.

Shkreli had been found not guilty on five other charges but had pleaded not guilty to all counts, calling the trial a "witch hunt of epic proportions."

Rewind: What Happened?

Shkreli co-founded MSMB Capital Management in 2009 and then co-founded and led Retrophin Inc RTRX in 2011. Retrophin terminated Shkreli in September 2014 and filed a $65 million suit in August 2015 for alleged misuse of company funds and violation of securities rules.

Prosecutors claimed Shkreli had lied to MSMB investors about the fund’s performance and, after the firm collapsed, paid them out with $11 million in Retrophin assets not authorized by the biotech board.

The FBI arrested Shkreli in December 2015, and he was subsequently indicted in Brooklyn’s Federal District Court for securities fraud and conspiracy. He posted a $5 million bail in January 2016 and began trial in June 2017.

Since then, his former attorney, Evan Greebel, was found guilty in the fraud case, and Netflix.com, Inc. NFLX released a documentary condemning his greed.

Context Of Character

These details round out a self-made persona widely pilloried.

Ahead of the legal ordeal, Shkreli had earned public censure for the price hikes of critical, unchallenged and potentially life-saving drugs at both Retrophin and Turing Pharmaceuticals.

He continued his provocation from prison with brazen attacks on public figures, including Merck & Co., Inc. MRK CEO Ken Frazier and Hillary Clinton. The latter offense — a public offering of $5,000 for a strand of Clinton’s hair — resulted in the revoking of a $5 million bail.

Related Links:

Turing Board Could Appoint Founder Martin Shkreli As CEO Or Chairman, But He Has No Interest

The Shkreli Top? History Could Be Repeating Itself

Image Credit: House Committee on Oversight and Government Reform [Public domain], via Wikimedia Commons

Posted In: fraudMartin ShkreliMSMB Capital ManagementSecurities FraudTuring PharmaceuticalsNewsHealth CareLegalTop StoriesGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.